Gemcitabine-Induced Activation of Checkpoint Signaling Pathways That Affect Tumor Cell Survival
Open Access
- 26 August 2005
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Molecular Pharmacology
- Vol. 68 (6), 1636-1644
- https://doi.org/10.1124/mol.105.012716
Abstract
Two signaling pathways are activated by antineoplastic therapies that damage DNA and stall replication. In one pathway, double-strand breaks activate ataxia-telangiectasia mutated kinase (ATM) and checkpoint kinase 2 (Chk2), two protein kinases that regulate apoptosis, cell-cycle arrest, and DNA repair. In the second pathway, other types of DNA lesions and replication stress activate the Rad9-Hus1-Rad1 complex and the protein kinases ataxia-telangiectasia mutated and Rad3-related kinase (ATR) and checkpoint kinase 1 (Chk1), leading to changes that block cell-cycle progression, stabilize stalled replication forks, and influence DNA repair. Gemcitabine and cytarabine are two highly active chemotherapeutic agents that disrupt DNA replication. Here, we examine the roles these pathways play in tumor cell survival after treatment with these agents. Cells lacking Rad9, Chk1, or ATR were more sensitive to gemcitabine and cytarabine, consistent with the fact that these agents stall replication forks, and this sensitization was independent of p53 status. Interestingly, ATM depletion sensitized cells to gemcitabine and ionizing radiation but not cytarabine. Together, these results demonstrate that 1) gemcitabine triggers both checkpoint signaling pathways, 2) both pathways contribute to cell survival after gemcitabine-induced replication stress, and 3) although gemcitabine and cytarabine both stall replication forks, ATM plays differential roles in cell survival after treatment with these agents.Keywords
This publication has 34 references indexed in Scilit:
- Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabineBlood, 2005
- G2 damage checkpoints: what is the turn-on?Journal of Cell Science, 2005
- Chk1 is Essential for Tumor Cell Viability Following Activation of the Replication CheckpointCell Cycle, 2004
- ATM is required for the cellular response to thymidine induced replication fork stressHuman Molecular Genetics, 2004
- Deletion of Mouse Rad9 Causes Abnormal Cellular Responses to DNA Damage, Genomic Instability, and Embryonic LethalityMolecular and Cellular Biology, 2004
- Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysisOncogene, 2004
- The Chk2 Tumor Suppressor Is Not Required for p53 Responses in Human Cancer CellsPublished by Elsevier BV ,2003
- Mismatch Repair in Human Nuclear ExtractsPublished by Elsevier BV ,2002
- Retention of the Human Rad9 Checkpoint Complex in Extraction-resistant Nuclear Complexes after DNA DamagePublished by Elsevier BV ,2000
- Atm-Deficient Mice: A Paradigm of Ataxia TelangiectasiaCell, 1996